TITLE:
Estimation of Thyroid Hormones Levels & Lung Function in Conventional Radiotherapy of Breast, Head and Neck Cancer’s
AUTHORS:
Mohammed A. Ali Omer, Abdulrahman A. S. Alsayyari, Abdullah Mohammed Aldokhail, Nasraldeen Alnaeem M. Alkhidir
KEYWORDS:
Breast, Head, Neck, Radiotherapy, Thyroid, Lungs
JOURNAL NAME:
Open Journal of Radiology,
Vol.9 No.4,
December
27,
2019
ABSTRACT: Consequences of breast, head and neck cancers (HNC) radiotherapy are common among developing country patients; hence the aim of this work was to assess the impact of HNC (nasopharyngeal, laryngeal and hypopharyngeal and parotid) radiotherapy in thyroid and lungs functions. The data (tumor dose, dose histogram) has been retrieved from treatment planning system (TPS) and the thyroid hormones (T3, T4 and TSH) level pre/post radiotherapy was measured by radioimmunoassay (RIA) technique. Ages (18 - 55 for HNC and 20 - 65 for breast cancer) derived from PACS and respiratory rate (RR) assessed by counting the number of breathing/minutes. The analyzed data using Excel showed that: the impact of HNC without parotid and supraclavicular irradiation was significant (P = 0.00) reduction on T3 & T4, and increasing TSH hormones relative to applied tumor dose. The average doses (2.8, 30, 32, 33 and 20.5 Gy) received by thyroid gland from irradiation of parotid, larynx, breast, hypopharynx and nasopharynx respectively reduced T4/T3 hormones to 125.9/0.8, 109/0.6, 67.8/0.4, 33.9/0.3 and 105.8/0.7 respectively and increased TSH to 4.5, 6.3, 8.1, 11.5 and 0.65 mU/l respectively. The RR increased significantly (P = 0.05) from 19.1 ± 3.6 to 22.1 ± 3.4 in average due to tangential fields irradiation of breast. Conclusion addressing that: conventional radiotherapy for HNC & breast induce a significant reduction in thyroid hormones and increment of RR.